Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $272.3K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NXTS, Q2 2026
No superinvestor reported holding NXTS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nexentis Technologies Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 (view filing) | Jan 29 | 56 daysLate | Lee Eun Young10% Owner | SSaleCommon Stock, par value $0.0001 per share | −127 | $1.36 | −$172.72 | 0.0%479.5K after | |
| Dec 26, 2024 (view filing) | Dec 23 | 3 days | Rosenbloom RonenDirector | PPurchaseRestricted Shares of Common Stock | +50.0K | $0.00 | $0 | +344.8%64.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Weiss AmitayDirector | PPurchaseRestricted Shares of Common Stock | +100.0K | $0.00 | $0 | New position100.0K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Rosenbloom RonenDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Kalifi Udi OvadiaDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | +366.4%18.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Berenstein Israel YakovDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Dec 26, 2023 (view filing) | Dec 20 | 6 daysLate | Arbib EliahouDirector | PPurchaseRestricted Shares of Common Stock | +14.5K | $0.00 | $0 | New position14.5K after | |
| Jul 26, 2022 (view filing) | Jun 15-16 | 41 daysLate | Kalifi Udi OvadiaDirector | PPurchase | +27.7K | $3.25 | +$90.1K | New position27.7K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Nexentis Technologies Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HRT Financial LP | 45,240 | $194.0K | 0.00% | +45,240 | New |
| Yorkville Advisors Global, LP | 16,409 | $70.7K | 0.08% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 998 | $4.30K | 0.00% | −5,989−85.7% | Reduced |
| Tower Research Capital LLC (TRC) | 736 | $3.17K | 0.00% | −3,766−83.7% | Reduced |
| SBI Securities Co., Ltd. | 32 | $138 | 0.00% | −26−44.8% | Reduced |
| Barclays PLC | 1 | $4 | 0.00% | +1 | New |